Navigation Links
Mayo Clinic reports new findings on noninvasive test for pancreatic cancer
Date:5/11/2011

ROCHESTER, Minn. - Pancreatic cancer has one of the highest mortality rates of any of the major cancers, and of the 43,000-plus Americans diagnosed with the disease each year, more than 94 percent die within five years of diagnosis. One reason for this high number of deaths is a lack of effective screening tools for catching the disease early. Now, in an effort to try to gain the upper hand on this deadly form of cancer, Mayo Clinic researchers believe they have found a new way to test for pancreatic cancer with DNA testing of patients' stool samples. The research was presented at the 2011 Digestive Disease Week conference, held May 7󈝶 in Chicago.

"We know with colon cancer that we can detect some molecular signatures of cancers and pre-cancers, and we were interested in trying to determine if we could do the same thing, specifically with a stool test, for pancreas cancer," says John Kisiel, M.D., Mayo Clinic gastroenterologist, who presented the study's findings.

The study focused on detecting methylations in stool samples of 127 patients, 60 diagnosed with pancreatic cancer and 67 who were not diagnosed with cancer. Methylation is a type of DNA modification strongly associated with cancers and pre-cancers. The research team wanted to test if they could reliably detect any types of methylated genes in the stool samples of those in the study group who had already been diagnosed with pancreatic cancer.

"We found that a marker was reliably detected in both tissue samples and in the stools of pancreatic cancer patients, and that it compared favorably with another kind of marker - the mutation of a gene called KRAS," says Dr. Kisiel. "When we looked at those two markers together, the combined accuracy of both markers was significantly better than with either marker alone." Overall, the methylated marker (called BMP3) and the mutated KRAS genes were detected in 70 percent of those in the study who had pancreatic cancer.

The screening detected the markers regardless of the stage of cancer or the location of the cancer within the pancreas. These findings may lead to more early detection of pancreatic cancer, which could significantly increase the survival rate for those who have the disease. The stool tests are also noninvasive, and samples can be collected by patients at home and sent to their doctor, without an office or clinic visit.

Ultimately, the researchers hope to expand on this initial study to create effective stool screenings for all the cancers that affect the gastrointestinal tract. "We now can reliably detect a methylation marker in stool that we know is present in curable stage cancers and similar markers have been found in pre-cancers," says Dr. Kisiel. "This is going to lead us to try to test additional patient tumor specimens for additional diagnostic markers of this type so that we can develop a panel of markers that could cover all the cancers and pre-cancers throughout the GI tract."


'/>"/>

Contact: Brian Kilen
newsbureau@mayo.edu
507-284-5005
Mayo Clinic
Source:Eurekalert

Related medicine news :

1. Watching how cancer patients interact online could help clinicians provide better services
2. Mayo Clinic researchers find new treatment for constipation
3. Mayo Clinic studies how much practice makes perfect when performing colonoscopies
4. Cedars-Sinais mobile medical clinics receive $500,000 grant from California Community Foundation
5. TGen licenses first drug for patient use in clinical care
6. Mayo Clinic CPR efforts successful on man with no pulse for 96 minutes
7. ENERCA clinical recommendations for sickle cell disease management and prevention in children
8. Mayo Clinic finds new genetic cause of neurodegeneration
9. Mayo Clinic finds robotic surgery effective for removing hard-to-reach throat cancer
10. UofL nursing faculty honored for race track clinic success
11. Tierney named 2011 Clinical and Translational Research Distinguished Investigator
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2016)... ... May 03, 2016 , ... Elizabeth Murray has always loved ... join her with one on her shoulder and one on her arm. But she ... because of years of mitral valve prolapse. , The valves of the heart wouldn’t ...
(Date:5/3/2016)... ... May 03, 2016 , ... University of the People, ... launch of its Associates and Bachelor's degrees in Health Studies. Leading figures are ... Dr. Torsten N. Wiesel; Chairman and CEO of Fortune 500® company Henry Schein, ...
(Date:5/3/2016)... ... ... Boston Children’s Hospital today announced its new pediatric Simulation (SIM) Center — ... procedures in an environment that looks and feels real. , Located in the heart ... “hackers” to develop and test new devices or software platforms and see how they ...
(Date:5/3/2016)... ... ... Park Cities Pet Sitter has openings for both full-time and part-time ... 75219, 75220, 75225, 75229, 75230, 75231 and 75235 zip codes. These zip codes ... and Park Cities areas of the Metroplex. Candidates must love animals, have attention ...
(Date:5/3/2016)... ... May 03, 2016 , ... ... industry, announced today that Legacy Health is expanding its use of Intrigma’s cloud-based ... a highly successful initial proof of concept. The Portland, Oregon based health system ...
Breaking Medicine News(10 mins):
(Date:4/29/2016)... April 29, 2016 ... Financier Sanofi, leader mondial ... ses résultats pour le premier trimestre ... Jérôme Contamine, commente les résultats du ... perspectives pour le reste de l,année. ...
(Date:4/28/2016)... 2016  While Abbott,s announced purchase of St. ... repair and stent business, healthcare research firm Kalorama ... firmly into patient monitoring.  Kalorama said that patient ... areas, with double-digit growth expected the next 5 ... Remote Patient Monitoring . Abbott Laboratories agreed ...
(Date:4/28/2016)... April 28, 2016  The blood testing market in ... according to Kalorama Information and The Freedonia Group in ... nucleic acid testing.  The healthcare research firm said that ... developing blood collection stations and in improving testing at ... Information,s report, Blood Testing Market in China ...
Breaking Medicine Technology: